🚀 VC round data is live in beta, check it out!
- Public Comps
- Ryan Specialty
Ryan Specialty Valuation Multiples
Discover revenue and EBITDA valuation multiples for Ryan Specialty and similar public comparables like Steadfast Group, Rasan, CorVel, Baldwin Insurance and more.
Ryan Specialty Overview
About Ryan Specialty
Ryan Specialty Holdings Inc is an international specialty insurance intermediary providing specialty products, solutions, and services for insurance brokers, agents, and carriers. The company offers wholesale insurance brokerage and delegated underwriting authority products and services, including distribution, underwriting, product development, administration, and risk management. Its expertise spans property, casualty, professional lines, transportation, personal lines, workers compensation, and employee benefits insurance, across traditional insurance and alternative risk solutions. The company operates in the United States and foreign markets, with the majority of revenue generated from the United States.
Founded
2021
HQ

Employees
6.1K
Website
Sectors
Financials (LTM)
EV
$8B
Ryan Specialty Financials
Ryan Specialty reported last 12-month revenue of $3B and EBITDA of $990M.
In the same LTM period, Ryan Specialty generated $990M in EBITDA and $567M in net income.
Revenue (LTM)
Ryan Specialty P&L
In the most recent fiscal year, Ryan Specialty reported revenue of $3B and EBITDA of $966M.
Ryan Specialty expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $3B | XXX | $3B | XXX | XXX | XXX |
| EBITDA | $990M | XXX | $966M | XXX | XXX | XXX |
| EBITDA Margin | 31% | XXX | 32% | XXX | XXX | XXX |
| EBIT Margin | 17% | XXX | 17% | XXX | XXX | XXX |
| Net Profit | $567M | XXX | $548M | XXX | XXX | XXX |
| Net Margin | 18% | XXX | 18% | XXX | XXX | XXX |
| Net Debt | — | — | $3B | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Ryan Specialty Stock Performance
Ryan Specialty has current market cap of $5B, and enterprise value of $8B.
Market Cap Evolution
Ryan Specialty's stock price is $37.45.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $8B | $5B | 0.0% | XXX | XXX | XXX | $4.26 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialRyan Specialty Valuation Multiples
Ryan Specialty trades at 2.6x EV/Revenue multiple, and 8.3x EV/EBITDA.
EV / Revenue (LTM)
Ryan Specialty Financial Valuation Multiples
As of April 20, 2026, Ryan Specialty has market cap of $5B and EV of $8B.
Equity research analysts estimate Ryan Specialty's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Ryan Specialty has a P/E ratio of 8.5x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $5B | XXX | $5B | XXX | XXX | XXX |
| EV (current) | $8B | XXX | $8B | XXX | XXX | XXX |
| EV/Revenue | 2.6x | XXX | 2.7x | XXX | XXX | XXX |
| EV/EBITDA | 8.3x | XXX | 8.5x | XXX | XXX | XXX |
| EV/EBIT | 15.4x | XXX | 16.1x | XXX | XXX | XXX |
| P/E | 8.5x | XXX | 8.8x | XXX | XXX | XXX |
| EV/FCF | 17.1x | XXX | 14.2x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Ryan Specialty Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Ryan Specialty Margins & Growth Rates
Ryan Specialty's revenue in the last 12 month grew by 11%.
Ryan Specialty's revenue per employee in the last FY averaged $0.5M.
Ryan Specialty's rule of 40 is 42% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Ryan Specialty's rule of X is 57% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Ryan Specialty Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 11% | XXX | 10% | XXX | XXX | XXX |
| EBITDA Margin | 31% | XXX | 32% | XXX | XXX | XXX |
| EBITDA Growth | 10% | XXX | 9% | XXX | XXX | XXX |
| Rule of 40 | — | XXX | 42% | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | 57% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.5M | XXX | XXX | XXX |
| G&A Expenses to Revenue | 14% | XXX | 74% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Ryan Specialty Public Comps
See public comps and valuation multiples for other Insurance Brokers comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Ryan Specialty | XXX | XXX | XXX | XXX | XXX | XXX |
| Steadfast Group | XXX | XXX | XXX | XXX | XXX | XXX |
| Rasan | XXX | XXX | XXX | XXX | XXX | XXX |
| CorVel | XXX | XXX | XXX | XXX | XXX | XXX |
| Baldwin Insurance | XXX | XXX | XXX | XXX | XXX | XXX |
| AUB Group | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Ryan Specialty M&A Activity
Ryan Specialty acquired XXX companies to date.
Last acquisition by Ryan Specialty was on XXXXXXXX, XXXXX. Ryan Specialty acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Ryan Specialty
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialRyan Specialty Investment Activity
Ryan Specialty invested in XXX companies to date.
Ryan Specialty made its latest investment on XXXXXXXX, XXXXX. Ryan Specialty invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Ryan Specialty
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Ryan Specialty
| When was Ryan Specialty founded? | Ryan Specialty was founded in 2021. |
| Where is Ryan Specialty headquartered? | Ryan Specialty is headquartered in United States. |
| How many employees does Ryan Specialty have? | As of today, Ryan Specialty has over 6K employees. |
| Who is the CEO of Ryan Specialty? | Ryan Specialty's CEO is Timothy W. Turner. |
| Is Ryan Specialty publicly listed? | Yes, Ryan Specialty is a public company listed on NYSE. |
| What is the stock symbol of Ryan Specialty? | Ryan Specialty trades under RYAN ticker. |
| When did Ryan Specialty go public? | Ryan Specialty went public in 2021. |
| Who are competitors of Ryan Specialty? | Ryan Specialty main competitors are Steadfast Group, Rasan, CorVel, Baldwin Insurance. |
| What is the current market cap of Ryan Specialty? | Ryan Specialty's current market cap is $5B. |
| What is the current revenue of Ryan Specialty? | Ryan Specialty's last 12 months revenue is $3B. |
| What is the current revenue growth of Ryan Specialty? | Ryan Specialty revenue growth (NTM/LTM) is 11%. |
| What is the current EV/Revenue multiple of Ryan Specialty? | Current revenue multiple of Ryan Specialty is 2.6x. |
| Is Ryan Specialty profitable? | Yes, Ryan Specialty is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Ryan Specialty? | Ryan Specialty's last 12 months EBITDA is $990M. |
| What is Ryan Specialty's EBITDA margin? | Ryan Specialty's last 12 months EBITDA margin is 31%. |
| What is the current EV/EBITDA multiple of Ryan Specialty? | Current EBITDA multiple of Ryan Specialty is 8.3x. |
| What is the current FCF of Ryan Specialty? | Ryan Specialty's last 12 months FCF is $479M. |
| What is Ryan Specialty's FCF margin? | Ryan Specialty's last 12 months FCF margin is 15%. |
| What is the current EV/FCF multiple of Ryan Specialty? | Current FCF multiple of Ryan Specialty is 17.1x. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.